In patients with HFpEF and obesity, both semaglutide (STEP-HFpEF) and tirzepatide (SUMMIT) significantly reduced cardiovascular death and worsening heart failure events, with concomitant improvements in quality of life and functional capacity [3,47]
Im so much more confident in myself, she shares
16 Patients with suspected Hirschsprung disease should be referred to a medical center with a pediatric gastroenterologist and surgeon for confirmatory testing with rectal suction biopsy
Occasional mild reactions may include temporary redness or soreness at the injection site, a brief metallic taste, or mild dizziness that quickly passes
Webinar Series DHS SBIR Phase 0 Webinar Series Explore past webinars featuring experts from DHS SBIR and program partner, Dawnbreaker, as they guide small businesses through the proposal process
For a sample cardiac risk calculator from the American Heart Association, click calculator